Panel Discussion: Bridging the Gaps Towards Implementing Minimal Residual Disease in Clinical Practice – A Collaborative View Across the Healthcare Ecosystem

Corporate Workshop Speaker(s)

• LL

  Lauren Leiman

  Executive Director
  BLOODPAC
• KB

  Kelli Bramlett

  Executive Director, R&D, Molecular Oncology
  Quest Diagnostics
• JD

  Jennifer Dickey

  Vice President, Regulatory and Quality
  Personal Genome Diagnostics
• CL

  Christina Lockwood

  Professor of Laboratory Medicine and Pathology
  University of Washington - School of Medicine, United States
• KP

  Krupa Paranjpe

  Global Stakeholder Relations Lead, Oncology
  Sanofi
• RD

  Ramin Dowlati

  Director Global Commercial Strategy Precision Medicine
  Johnson & Johnson